LONG COVID-19
Clinical trials for LONG COVID-19 explained in plain language.
Never miss a new study
Get alerted when new LONG COVID-19 trials appear
Sign up with your email to follow new studies for LONG COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain zaps for brain fog? new study tests rTMS for Long-COVID
Symptom relief OngoingThis small pilot study tests whether a non-invasive brain stimulation technique called rTMS can safely reduce fatigue, brain fog, and other neuropsychiatric symptoms in people with Long-COVID. Ten adults with confirmed Long-COVID will receive either real or sham rTMS for 15 sessi…
Matched conditions: LONG COVID-19
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated May 26, 2026 06:09 UTC
-
Could a gut drug ease long COVID? new trial tests larazotide in kids and adults
Symptom relief OngoingThis study tests whether the drug larazotide can safely reduce Long COVID symptoms in 107 people aged 7 to 50. Participants take either the drug or a placebo four times a day for 21 days. The goal is to see if the drug helps with symptoms like fatigue, brain fog, and breathing tr…
Matched conditions: LONG COVID-19
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 05:58 UTC
-
New study aims to get long COVID patients moving again
Symptom relief OngoingThis study tests different treatments to help people with Long COVID who have trouble exercising or feel very tired after activity. It will include 360 participants and measure how well they can walk and perform daily tasks. The goal is to find safe ways to improve their quality …
Matched conditions: LONG COVID-19
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 26, 2026 05:49 UTC
-
New study targets long COVID sleep troubles
Symptom relief OngoingThis study tests different treatments to help people with Long COVID who have sleep problems like insomnia, daytime sleepiness, or irregular sleep patterns. About 470 adults will be randomly assigned to receive a treatment or a placebo. The goal is to see if these treatments can …
Matched conditions: LONG COVID-19
Phase: PHASE2 • Sponsor: Duke University • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC
-
New study targets long COVID sleep troubles
Symptom relief OngoingThis study is for people with Long COVID who have sleep issues like feeling very sleepy during the day or having trouble sleeping at night. Researchers will test different treatments to see which ones help improve sleep and reduce daytime tiredness. About 361 adults will take par…
Matched conditions: LONG COVID-19
Phase: PHASE2 • Sponsor: Duke University • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC
-
Skin biopsies could unlock long COVID mysteries
Knowledge-focused OngoingThis study looks at tiny nerve changes in the skin of people with Long COVID, POTS, or diabetic neuropathy. Researchers will compare these changes to better understand how these conditions affect the body's sensory and automatic nervous systems. 300 participants will provide a si…
Matched conditions: LONG COVID-19
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 06:00 UTC